Alivus Life Sciences has published notices for its 14th Annual General Meeting (AGM), which will be held virtually via video conferencing or other audio-visual means. Shareholders have been sent the AGM notice and the Integrated Annual Report for the Financial Year 2024-25 via email. The company is providing an e-voting facility, allowing shareholders to cast their votes on the resolutions proposed at the AGM, ensuring their participation in this important governance event.